[Laryngeal carcinoma: retrospective study of 82 cases].
Between 1988-93, 82 cases of laryngeal carcinomas were diagnosed and treated at the Hospital of Rovigo. All were retrospectively staged using the TNM system. The actuarial global and NED survival were respectively 65.85% and 58.54% for 5 years. In relation to the site the survival for 5 years was 66.04% for the supraglottic tumours, 70.83% for the glottic tumours, 50% for the subglottic tumours and 33.33% for the transglottic ones. The grade of differentiation was certified in all cases: 15 (18.3%) G1, 58 (70.7%) G2, 9 (11%) G3. The NED survival and the recurrences for 3 years were found to be 90% and 0% of G1, 64.10% and 15.38% of G2, 66.67% and 33.33% of G3. The NED survival and the recurrences for 3 years were stage I, 73.91% and 13.4%; stage II 63.64% and 18.18%; stage III 50% and 15%; stage IV 47% and 17.65%. On the basis of the results obtained from our study, we were able to formulate some considerations upon the use of therapy adopted.
Borghi
L
L
Servizio di Anatomia ed Istologia Patologica, Ospedale Civile, Rovigo.
Ballotta
M R
MR
Migliorini
V
V
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015996:Survival Rate